InvestorsHub Logo
Followers 19
Posts 3820
Boards Moderated 0
Alias Born 09/23/2014

Re: Honeycomb777 post# 86684

Sunday, 04/28/2019 9:35:29 PM

Sunday, April 28, 2019 9:35:29 PM

Post# of 140502
Be realistic - the smart move is to go the single specialty route (in this case GYN) for regulatory approval. Same thing ISRG did with their SP platform and it will quickly evolve from there.

Keep it Simple - get the GYN clinical, safety and efficacy data - focus on the most common current robotic areas - get approval.

IMO - $6B the minimum.